EP300 and head and neck squamous cell carcinoma: However, in skin cancer, osteosarcoma, myelodysplastic syndrome (MDS)-related leukemia, and human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC), p300 plays a tumor-suppressive role [24,25,26,27].